Buena Park, CA
Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.
capsida.comThese are collections Capsida Biotherapeutics is a part of. Click on the collection name to view similar companies.
Series A
$50,000,000
Corporate Round
$90,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Capsida Biotherapeutics.